Pharmacological features of the gall bladder and its vascular bed of the dog in situ.
D000818:Animals; D001158:Arteries / Q000187:drug effects; D001464:Barium / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000494:pharmacology; D003864:Depression, Chemical; D004285:Dogs; D005260:Female; D005704:Gallbladder / Q000098:blood supply* / Q000187:drug effects*; D005730:Ganglionic Blockers / Q000494:pharmacology; D005731:Ganglionic Stimulants / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D009705:Nucleosides / Q000494:pharmacology; D009711:Nucleotides / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D011343:Procaine / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D013268:Stimulation, Chemical; D013566:Sympathomimetics / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology
D005730:Ganglionic Blockers; D005731:Ganglionic Stimulants; D009705:Nucleosides; D009711:Nucleotides; D010277:Parasympathomimetics; D010455:Peptides; D013566:Sympathomimetics; D001464:Barium; D012701:Serotonin; D011343:Procaine; D010042:Ouabain; D011189:Potassium Chloride; D006632:Histamine; D013806:Theophylline; D010208:Papaverine; D008274:Magnesium; D002118:Calcium